Skip to main content
Figure 3 | Molecular Medicine

Figure 3

From: Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot Study

Figure 3

A higher proportion of ARA 290 patients exhibited a superior improvement than placebo patients in the SFNSL score at all levels of response. Cumulative proportion of responder analysis summarizes that across a wide range of score improvements a greater proportion of ARA 290 patients reached a specific level of reduction in the SFNSL score than placebo patients.

Back to article page

Molecular Medicine

ISSN: 1528-3658